(Q39718320)

14 September 2017

1 reference

title

Metabolism of hydralazine (English)

1 reference

14 September 2017

Metabolism of Hydralazine (English)

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

2 April 2023

author name string

Z. H. Israili

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A344023

2 April 2023

P. G. Dayton

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A344023

2 April 2023

language of work or name

English

0 references

publication date

1 January 1977

1 reference

full work available at URL

14 September 2017

http://www.tandfonline.com/doi/pdf/10.3109/03602537708997482

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

2 April 2023

published in

Drug Metabolism Reviews

1 reference

14 September 2017

volume

6

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

283-305

1 reference

Studies on hydralazine; evidence for a peripheral site of action

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F03602537708997482

Cardiovascular and renal adjustments to a hypotensive agent (l'hydrazinophthalazine: Ciba BA-5968: apresoline)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537708997482

Renal and hemodynamic effects of combination therapy in hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537708997482

Identification and Quantitation of Impurities in Dapsone Preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537708997482

3-Hydroxymethyl-s-triazolo[3,4-a]phthalazine, a novel urinary hydralazine metabolite in man

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537708997482

Fluorescence of hydralazine in concentrated sulfuric acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537708997482

Disposition of hydralazine in man and a specific method for its determination in biological fluids.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537708997482

Identification of two new metabolites of hydralazine from human urine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537708997482

Liquid Chromatography in Pharmaceutical Analysis III: Separation of Diuretic‐Antihypertensive Mixtures

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537708997482

Studies on hydralazine. II. Elimination rate and steady-state concentration in patients with impaired renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537708997482

Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537708997482

Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537708997482

Inhibition of monoamine oxidase by substituted hydrazines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537708997482

The interaction of lupus-inducing drugs with deoxyribonucleic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537708997482

Hydralazine therapy in hypertensive patients with idiopathic systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537708997482

The Effect of Intense Treatment with Hypotensive Drugs on Structural Design of the Resistance Vessels in Spontaneously Hypertensive Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537708997482

A Paradoxical Cerebral Hemodynamic Effect of Hydralazine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537708997482

Collagen Biosynthesis in Blood Vessels of Brain and Other Tissues of the Hypertensive Rat

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537708997482

Acute and subacute toxicity of an adduct of hydralazine and a 3-ketoalkylthiazide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537708997482

LD50 determination and hypotensive effect of 3-methyl-2-benzothiazolone hydrazone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537708997482

Renal hyperemia induced in man by a new phthalazine derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537708997482

Relation of hydralazine plasma concentration to dosage and hypotensive action

21 January 2018

5

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

The hemodynamic effects of hypotensive drugs in man. IV. 1-Hydrazinophthalazine

2 April 2023

6

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade

2 April 2023

8

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

[The importance of experimental analysis for the therapeutic use of hypotensive drugs]

2 April 2023

9

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Treatment of hypertension with oral reserpine alone and in combination with hydralazine or hexamethonium

2 April 2023

11

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Eine neue Gruppe blutdrucksenkender Substanzen von besonderem Wirkungscharakter

2 April 2023

12

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Evaluation of l-hydrazinophthalazine (apresoline) in treatment of hypertensive disease

2 April 2023

14

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Hypotensive hydrazinophthalazines and related compounds

2 April 2023

15

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Hydrazinderivate der Phtalazin- und Pyridazinreihe

2 April 2023

18

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

[Phthalazines. VII. On the reaction of 1-(methylsulfonyl)-phthalazine with nucleophiles]

2 April 2023

21

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Hydralazine elimination in man

2 April 2023

23

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

1,214-Triazoles. XXII. Derivatives of the s-triazolo [3,4-alpha] phthalazine and related ring systems

2 April 2023

27

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Drug Metabolism and Disposition

2 April 2023

28

2

351

Lesser J. M.

1974

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

2 April 2023

30

30

3024

Gabriel S.

1897

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

2 April 2023

31

26

526

Gabriel S.

1893

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Determination of hydralazine and its metabolites by gas chromatography-mass spectrometry

2 April 2023

35

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

THE METABOLIC FATE OF 1,4-DIHYDROXYPHTHALAZINE-1-14-C

2 April 2023

36

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Journal of Pharmacology and Experimental Therapeutics

2 April 2023

44

143

7

McLsaac W. M.

1964

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Effect of ring substitution on the hemolytic action of arylhydrazines

2 April 2023

46

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

INFLUENCE OF HYDRALAZINE ON THE SULFHYDRYL GROUP IN THE PRESENCE OF CUPRIC ION

2 April 2023

49

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

A metabolite of 1-hydrazinophthalazine (hydralazine)

2 April 2023

55

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

The determination of hydralazine in plasma by gas-liquid chromatography

2 April 2023

57

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

2 April 2023

60

18

196

Israili Z. H.

1976

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Simultaneous automated determination of hydralazine hydrochloride, hydrochlorothiazide, and reserpine in single tablet formulations

2 April 2023

64

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Proceedings of the Society for Experimental Biology and Medicine

2 April 2023

74

32

44G

Johnson W.

1956

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

2 April 2023

Molecular Pharmacology

76

3

2GG

Weber W. W.

1967

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Purification and properties of N-acetyltransferase from mammalian liver

2 April 2023

78

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Hydralazine urinary metabolites in systemic lupus erythematosus

2 April 2023

79

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Pyridoxine-Deficiency Neuropathy Due to Hydralazine

2 April 2023

81

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydrazine metabolites

2 April 2023

83

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Metabolism of methylscopolammonium methylsulfate (DD-234) in rats

2 April 2023

85

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Duration of hydralazine action in hypertension

2 April 2023

86

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

CONJOINT CLINIC ON DRUGS AND GENES

2 April 2023

91

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Clinical Pharmacology & Therapeutics

2 April 2023

92

14

1402

Lesser J. M.

1973

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Acetylator phenotype and the antihypertensive response to hydralazine

2 April 2023

95

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

2 April 2023

97

16

196

Dayton P. G.

1974

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

The effects of hydrazine and guanylhydrazone derivatives on the activity of monoamine oxidase, diamine oxidase, DOPA decarboxylase and histidine decarboxylase

2 April 2023

101

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

[Inhibition of histaminase by phthalazin derivatives]

2 April 2023

105

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Monoamine oxidase inhibitors and other drugs as inhibitors of diamine oxidase from human placenta and pig kidney

2 April 2023

106

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Effects of transition metals and of metal-binding antihypertensive agents on tryptamine oxidase and dopa decarboxylase

2 April 2023

108

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Inhibition of dopamine-beta-hydroxylase by hydralazine

2 April 2023

109

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

2 April 2023

110

18

161

Sprouse J. S.

1976

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

PROLONGATION OF HEXOBARBITAL SLEEPING TIME AND INHIBITION OF HEPATIC DRUG METABOLISM BY ADRENERGIC BLOCKING AGENTS IN MICE

2 April 2023

112

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Inhibition of drug-metabolizing enzymes of liver microsomes by hydrazine derivatives in relation to their lipid solubility

2 April 2023

113

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Hydralazine-induced disturbances in collagen biosynthesis

2 April 2023

114

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Immunological studies of collagens modified by reaction with hydralazine

2 April 2023

115

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

2 April 2023

121

44

664

Alarcon-Segovia D

1969

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Clinical and experimental studies on the hydralazine syndrome and its relationship to systemic lupus erythematosus

2 April 2023

122

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Effect of Treatment on Longevity in Spontaneously Hypertensive Rats

2 April 2023

128

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Journal of Pharmacology and Experimental Therapeutics

2 April 2023

132

101

368

Walker H. A.

1951

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

Clinical Pharmacology & Therapeutics

2 April 2023

141

19

110

LeSher D. A.

1976

1 reference

https://api.crossref.org/works/10.3109/03602537708997482

2 April 2023

Identifiers

1 reference

14 September 2017

1 reference